This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US
September 23-26, 2024
Hynes Convention CenterBoston, MA

Amol Ketkar
CMTO (Chief Manufacturing and Technical Officer) at Resolution Therapeutics


Amol Ketkar, Chief Manufacturing and Technical Operations Officer (CMTO), Resolution Therapeutics. As CMTO, Amol covers all aspects of CMC and his group develops and manufactures macrophage-based therapies while ensuring compliance and developing regulatory strategies to deliver these products.

Amol has over 25 years of experience in pharmaceutical development and manufacturing. Most recently, he was at GlaxoSmithKline (GSK) where he worked for approximately 21 years in various roles. Amol’s role in GSK was as Vice-President, Product Development and Supply for GSK’s Cell and Gene Therapy CMC group. Prior to that, Amol held positions of increasing responsibility within GSK’s Biopharm group and worked across the development lifecycle from pre-candidate selection to post commercial support.

Amol has a Bachelor’s degree in Pharmacy from the University of Bombay, Ph.D. in Pharmaceutics from The Ohio State University, and post-doctoral training from University of Iowa.

Agenda Sessions

  • Building a Collaborative Distributed Manufacturing Ecosystem


At this event